Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Prevalence of hepatitis A antibodies in Eastern Bolivia: a population-based study.

C MA, J M RT, A CR, M BN, M DG, S L MR.

J Med Virol. 2013 Oct;85(10):1692-7. doi: 10.1002/jmv.23671. Epub 2013 Jul 16.

PMID:
23861034
2.

Hepatitis A seroprevalence in children and adolescents aged 1-18 years among a low socioeconomic population in Izmir, Turkey.

Halicioglu O, Akman SA, Tatar B, Atesli R, Kose S.

Travel Med Infect Dis. 2012 Jan;10(1):43-7. doi: 10.1016/j.tmaid.2012.01.001. Epub 2012 Jan 20.

PMID:
22264583
3.

Impact of travel on the seroprevalence of hepatitis A in children.

Faillon S, Martinot A, Hau I, Puget A, Moulin F, Noel G, Guen CG, Lorrot M, Callamand P, Hue V, Meritet JF, Gendrel D, Dubos F.

J Clin Virol. 2013 Jan;56(1):46-51. doi: 10.1016/j.jcv.2012.10.004. Epub 2012 Nov 3.

PMID:
23127561
4.

Seroprevalence of varicella-zoster virus infection in children from Cochabamba: tropical or temperate pattern?

Masuet-Aumatell C, Ramon-Torrell JM, Casanova-Rituerto A, Banqué-Navarro M, Dávalos-Gamboa Mdel R, Montaño-Rodríguez SL.

Trop Med Int Health. 2013 Mar;18(3):296-302. doi: 10.1111/tmi.12040. Epub 2012 Dec 20.

5.

Seroprevalence of hepatitis A virus infection among schoolchildren and adolescents in Kaduna, Nigeria.

Afegbua SL, Bugaje MA, Ahmad AA.

Trans R Soc Trop Med Hyg. 2013 Oct;107(10):627-30. doi: 10.1093/trstmh/trt072. Epub 2013 Aug 19.

PMID:
23959003
6.
7.

Changing epidemiology of hepatitis A infection in Izmir, Turkey.

Kurugol Z, Aslan A, Turkoglu E, Koturoglu G.

Vaccine. 2011 Aug 26;29(37):6259-61. doi: 10.1016/j.vaccine.2011.06.069. Epub 2011 Jul 18.

PMID:
21763745
8.

Declining prevalence of hepatitis A virus antibodies among children from low socioeconomic groups reinforces the need for the implementation of hepatitis A vaccination in Brazil.

Vitral CL, Ospina FL, Artimos S, Melgaço JG, Cruz OG, de Paula VS, Luz SB, Freire M, Gaspar LP, Amado LA, Engstrom EM, Fortes CD, Souza TC, Dias MN, Gaspar AM, Souto FJ.

Mem Inst Oswaldo Cruz. 2012 Aug;107(5):652-8.

9.

Seroprevalence of hepatitis A virus antibodies (anti-HAV) in adult inhabitants of Wielkopolska region, Poland--the role of simple demographic factors.

Bura M, Bura A, Adamek A, Michalak M, Marszałek A, Hryckiewicz K, Mozer-Lisewska I.

Ann Agric Environ Med. 2012;19(4):738-41.

10.

[Sociodemographical aspects of seroprevalence of hepatitis A virus in the settlement of Cavunge, a semi-arid region of Bahia State].

Almeida D, Tavares-Neto J, Queiroz-Andrade M, Dias C, Ribeiro T, Silva F, Silva-Araújo J, Tatsch F, Paraná R.

Rev Soc Bras Med Trop. 2006 Jan-Feb;39(1):76-8. Epub 2006 Feb 23. Portuguese.

11.

Present epidemiological pattern of antibody to hepatitis a virus among Chiang Mai children, Northern Thailand.

Jutavijittum P, Jiviriyawat Y, Jiviriyawat W, Yousukh A, Hayashi S, Toriyama K.

Southeast Asian J Trop Med Public Health. 2002 Jun;33(2):268-71.

PMID:
12236424
12.

Hepatitis A and E seroprevalence and associated risk factors: a community-based cross-sectional survey in rural Amazonia.

Vitral CL, da Silva-Nunes M, Pinto MA, de Oliveira JM, Gaspar AM, Pereira RC, Ferreira MU.

BMC Infect Dis. 2014 Aug 23;14:458. doi: 10.1186/1471-2334-14-458.

13.

Prevalence and risk factors of hepatitis A among blood donors in Qazvin, central Iran.

Ramezani H, Bozorgi SH, Nooranipour M, Mostajeri A, Kargar-Fard H, Molaverdikhani S, Mazdaki A, Alavian SM.

Singapore Med J. 2011 Feb;52(2):107-12.

14.

Seroepidemiology of hepatitis A among Greek children indicates that the virus is still prevalent: Implications for universal vaccination.

Kyrka A, Tragiannidis A, Cassimos D, Pantelaki K, Tzoufi M, Mavrokosta M, Pedeli X, Athanassiadou F, Hatzimichael A, Konstantopoulos A, Kafetzis D, Papaevangelou V.

J Med Virol. 2009 Apr;81(4):582-7. doi: 10.1002/jmv.21434.

PMID:
19235841
15.

Seroprevalence of hepatitis A virus antibody in a population aged 0-30 years in Shanghai, China: implications for hepatitis A immunization.

Zhu Y, Yuan Z, Zhao Q, Chen G, Xu B.

Epidemiol Infect. 2013 Mar;141(3):556-62. doi: 10.1017/S0950268812001161. Epub 2012 Jun 12.

PMID:
22687628
16.

Prevalence of IgG anti-HAV in patients with chronic hepatitis B and in the general healthy population in Korea.

Lee SH, Kim HS, Park KO, Park JW, Chun SY, Lim SJ, Cho HJ, Kim SJ, Park HW, Moon HK, Shin WG, Kim KH, Jang MK, Lee JH, Kim HY.

Korean J Hepatol. 2010 Dec;16(4):362-8. doi: 10.3350/kjhep.2010.16.4.362.

17.

Hepatitis A virus age-specific sero-prevalence and risk factors among Jordanian children.

Hayajneh WA, Balbeesi A, Faouri S.

J Med Virol. 2015 Apr;87(4):569-74. doi: 10.1002/jmv.24137. Epub 2015 Feb 3.

PMID:
25648328
18.

Seroprevalence of hepatitis A virus antibody in Bijapur, Karnataka.

Rath CP, Akki A, Patil SV, Kalyanshettar SS.

Indian Pediatr. 2011 Jan;48(1):71-3.

PMID:
21317475
19.

The relation between anti-hepatitis A virus antibodies and residence water access in Rio de Janeiro, Brazil.

Luiz RR, Almeida RM, Almeida RT, de Almeida LM.

Int J Hyg Environ Health. 2003 Oct;206(6):575-82.

PMID:
14626904
20.

[Prevalence of anti-hepatitis A virus antibodies in chidren in Marrakech].

Bouskraoui M, Bourrous M, Amine M.

Arch Pediatr. 2009 Oct;16 Suppl 2:S132-6. doi: 10.1016/S0929-693X(09)75317-5. French.

PMID:
19836677

Supplemental Content

Support Center